GlassScriptPhysician profile
Marlon K Weiss
NPI 1285663708
$1,710.14
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,245 · 2020: $398 · 2021: $15.24 · 2022: $52.31.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $459.86 | 2019-2020 | |
| Allergan, INC. | $281.18 | 2019-2020 | |
| Novo Nordisk INC | $142.16 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $119.99 | 2019 | |
| Alkermes, INC. | $112.65 | 2019 | |
| Sunovion Pharmaceuticals INC. | $96.19 | 2019-2020 | |
| Neurocrine Biosciences, INC. | $79.10 | 2019 | |
| Glaxosmithkline, LLC. | $76.69 | 2019 | |
| Optinose US, INC. | $69.74 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $52.31 | 2022 | |
| Jazz Pharmaceuticals INC. | $45.26 | 2019-2020 | |
| Ironshore Pharmaceuticals INC. | $27.15 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.91 | 2019 | |
| Shire North American Group INC | $22.61 | 2019 | |
| Boston Scientific Corporation | $17.73 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alfasigma USA, INC. | $16.09 | 2020 | |
| Adlon Therapeutics L.P. | $15.25 | 2019 | |
| Abbvie INC. | $15.24 | 2021 | |
| Sanofi Pasteur INC. | $13.30 | 2019 | |
| Lilly USA, LLC | $13.09 | 2019 | |
| Janssen Pharmaceuticals, INC | $11.64 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marlon Weiss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.